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ABSTRACT
NAD glycohydrolase (EC 3.2.2.5) (NADase) sequences have been identified in 10
elapid and crotalid venom gland transcriptomes, eight of which are complete. These
sequences show very high homology, but elapid and crotalid sequences also display
consistent differences. As in Aplysia kurodai ADP-ribosyl cyclase and vertebrate CD38
genes, snake venomNADase genes comprise eight exons; however, in the Protobothrops
mucrosquamatus genome, the sixth exon is sometimes not transcribed, yielding a
shortened NADase mRNA that encodes all six disulfide bonds, but an active site
that lacks the catalytic glutamate residue. The function of this shortened protein, if
expressed, is unknown. While many vertebrate CD38s are multifunctional, liberating
both ADP-ribose and small quantities of cyclic ADP-ribose (cADPR), snake venom
CD38 homologs are dedicated NADases. They possess the invariant TLEDTL sequence
(residues 144–149) that bounds the active site and the catalytic residue, Glu228. In
addition, they possess a disulfide bond (Cys121–Cys202) that specifically prevents
ADP-ribosyl cyclase activity in combination with Ile224, in lieu of phenylalanine,
which is requisite for ADPR cyclases. In concert with venom phosphodiesterase
and 5′-nucleotidase and their ecto-enzyme homologs in prey tissues, snake venom
NADases comprise part of an envenomation strategy to liberate purine nucleosides,
and particularly adenosine, in the prey, promoting prey immobilization via hypotension
and paralysis.
Subjects Biochemistry, Genomics, Toxicology, Zoology
Keywords Snake venom, NAD glycohydrolase, NADase, CD38, ADP-ribosyl cyclase,
Protobothrops mucrosquamatus genome, Exons, Adenosine, Phosphodiesterase, 5′-nucleotidase
INTRODUCTION
More than 60 years ago, Bhattacharya (1953) reported that when Bungarus fasciatus venom
is incubated with NAD, it releases nicotinamide. This constituted the first evidence that
some snake venoms contain an NAD glycohydrolase (NADase) (EC 3.2.2.5). However, like
many other non-toxic enzymes, its presence in venoms seemed enigmatic until Aird (2002)
proposed that purine nucleosides comprise core elements of the envenomation strategies
of most advanced venomous snakes. Adenosine is particularly important because of its
hypotensive and neuroprotective (neurosuppressive) activities. Venom NADase augments
How to cite this article Koludarov I, Aird SD. 2019. Snake venom NAD glycohydrolases: primary structures, genomic location, and gene
structure. PeerJ 7:e6154 http://doi.org/10.7717/peerj.6154
Table 1 Species negative for NADase activity, according to Tatsuki et al. (1975).
Elapidae Viperidae Crotalidae
Dendroaspis angusticeps Bitis arietans Bothrops atrox
Dendroaspis polylepis Bitis gabonica Crotalus adamanteus
Hemachatus haemachatus Daboia russellii Crotalus atrox
Naja atra Daboia palestinae Crotalus basiliscus
Naja haje Echis carinatus Crotalus durissus terrificus
Naja melanoleuca Vipera ammodytes Crotalus viridis viridis
Naja nivea Ovophis okinavensis
Ophiophagus hannah Protobothrops flavoviridis
Protobothrops mucrosquamatus
adenosine release in prey tissues by cleaving β-NAD and NADP to nicotinamide and ADP-
ribose, from which adenosine can be liberated by venom and tissue phosphodiesterases in
combination with venom and tissue 5′-nucleotidases. Recently, it has been reported that
the Deinagkistrodon acutus NADase is capable of hydrolyzing both ATP and ADP to AMP,
a function normally supplied by phosphodiesterase (Zhang et al., 2009).
Historical overview of studies on snake venom NADase
Seven years after the Bhattacharya study, Suzuki, Iizuka & Murata (1960) examined 9
Asian snake venoms for NADase activity, using the UV detection method (340 nm) of
Zatman, Kaplan & Colowick (1953) and discovered this enzyme in the venoms of Bungarus
multicinctus and Trimeresurus gramineus. Venoms reported as negative for NADase
included Gloydius blomhoffii, Deinagkistrodon acutus, Ovophis okinavensis, Protobothrops
mucrosquamatus, Naja atra, Naja naja, and Ophiophagus hannah.
In a study of 37 elapid, viperid and crotalid venoms, also using UV detection, Tatsuki et
al. (1975) confirmed the earlier findings of NADase activity in venoms of the two Bungarus
species and further identified it in venoms of Agkistrodon c. contortrix, A. c. mokasen,
A. c. laticinctus, A. p. piscivorus, Gloydius blomhoffii, Deinagkistrodon acutus, and Causus
rhombeatus, the first viperid examined. All other taxa were reportedly negative for NADase
activity (Table 1). Using a succession of five liquid chromatographic procedures they
isolated the enzyme from G. blomhoffii venom and characterized it biochemically. The
Gloydius enzyme readily hydrolyzed β-NAD and NADP+, and cleaved 3-acetylpyridine
adenine dinucleotide, but it did not hydrolyze NADH, NADPH, α-NAD+, or β-
nicotinamide mononucleotide (β-NMN) (Tatsuki et al., 1975). They did not estimate
the enzyme’s molecular weight.
Yost & Anderson (1981) characterized the NADase from Bungarus fasciatus venom, and
reported that it was a homodimeric glycoprotein of 120–130,000 Da, having a monomeric
molecular weight of 62,000 (denaturing SDS PAGE). The enzyme comprised approximately
0.1% of Bungarus fasciatus venom by mass (Yost & Anderson, 1981; Anderson, Yost &
Anderson, 1986) while a value of 0.5% was reported from Deinagkistrodon acutus venom
(Wu et al., 2002) using a simpler chromatographic procedure with more sophisticated
resins.
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Huang et al. (1988) investigated the NADase from Deinagkistrodon acutus venom. That
enzyme is a homodimeric glycoprotein of about 98,000 Da, having a minimummonomeric
molecular mass of 33,500 Da, allowing for a carbohydrate content estimated at 33%. The
authors reported that the N-terminal amino acid was proline. As with the Gloydius
enzyme (Tatsuki et al., 1975), NADP was the optimal substrate (Huang et al., 1988). The
Deinagkistrodon NADase is a metalloenzyme, containing a single, essential copper ion.
Despite these studies, no structural information has been reported for any snake venom
NADase. Because our group has completed a series of elapid and crotalid venom gland
transcriptomic studies employing high-throughput techniques (Aird et al., 2013; Aird et
al., 2015; Aird et al., 2017b), we searched these transcriptomes for the presence of NAD
glycohydrolase. It was found in all of them, and we here report their primary structures,
possible 3D structures, genomic arrangement, and gene structure.
MATERIALS & METHODS
The NADase sequences examined were generated in previously reported studies (Aird
et al., 2013; Aird et al., 2015; Aird et al., 2017b). Models of the Micrurus surinamensis
and Protobothrops mucrosquamatus NADases and human CD38 were created using
GalaxyTBM (Ko et al., 2012) (http://galaxy.seoklab.org/cgi-bin/submit.cgi?type=TBM).
Three-dimensional structures were visualized and analyzed using Chimera version 1.13
(Pettersen et al., 2004) (http://www.rbvi.ucsf.edu/chimera). Probable disulfide bonds were
created manually based upon cysteine locations and energy minimizations were performed
thereafter to optimize the structures. Hydrophilicity/hydrophobicity scores were calculated
using the Gravy calculator at: http://www.gravy-calculator.de.
Geneious 8.1.9 (https://www.geneious.com) was used to BLAST elapid and crotalid
transcriptomes for NAD glycohydrolase sequences using Gallus gallus CD38 as a query
sequence and to align snake venom sequences (Table 2). Genomic scaffolds were examined
with ncbi-blast/2.7.1+ suite (https://blast.ncbi.nlm.nih.gov) usingHomo sapiensCD38 and
Protobothrops mucrosquamatus CD38 as queries and further analyzed in Geneious 8.1.9 to
determine exon sequences (Table 2).
RESULTS & DISCUSSION
Snake venom NADase amino acid sequences
The NCBI Protein site was searched for vertebrate NAD glycohydrolase sequences and
the sequence of chicken ADP-ribosyl cyclase (ADQ89191.1), also known as CD38, was
downloaded for use as a query sequence. TBLASTN searches of venomgland transcriptomes
of 10 elapid and crotalid species were performed using Geneious 8.1.9. A highly similar
sequence was identified in each transcriptome, eight of which were complete (Fig. 1), and
NADase transcripts were present at low levels in venom gland transcriptomes of all 30
Protobothrops mucrosquamatus examined by (Aird et al., 2017a). A partial (30-residue),
unidentified sequence also occurs in the Ophiophagus hannah genome (L345_15802). The
former sequences were aligned with CD38 sequences from Gallus gallus, Xenopus laevis,
Anolis carolinensis, and Homo sapiens, using Geneious (Fig. 1).
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Table 2 Transcript IDs and protein accession numbers used in this study.
Taxon Name Scaffold ID Gene ID Transcript ID
Homo sapiens CD38 NC_000004.12 952 NM_001775.3
Thamnophis sirtalis CD38 NW_013658259 106543891 XM_014059996.1
Python bivittatus CD38 NW_006532481 103059310 XM_007424863.2
Anolis carolinensis CD38 NC_014779 100566030 XM_016993323.1
Xenopus laevis CD38 NC_030724.1 100036901 NM_001097679.1
Protobothrops mucrosquamatus Long CD38 NW_015387543 107292463 XM_015821551.1
Protobothrops mucrosquamatus Short CD38 NW_015387543 107292463 XM_015821552.1
Accession #
Gallus gallus CD38 NCBI ADQ89191.1
Transcript ID
Micrurus carvalhoi CD38 DN61384_c0_g1_i1|m.5640
Micrurus corallinus CD38 DN100482_c0_g2_i2|m.92
Micrurus lemniscatus CD38 DN22889_c0_g1_i1|m.65259
Micrurus paraensis CD38 DN86064_c0_g1_i1|m.15110
Micrurus spixii CD38 DN121140_c2_g1_i1|m.22327
Micrurus surinamensis CD38 DN77054_c0_g1_i1|m.2918
Ovophis okinavensis CD38 Oo_comp19518_c0_seq1
Protobothrops elegans CD38 Pe_comp350_c0_seq1
Protobothrops flavoviridis CD38 Pf_comp3789_c0_seq1
None of the venom NADases appears to have a signal peptide, based upon sequence
analyses using SignalP 4.1 (Petersen et al., 2011). All are readily distinguished from the
former four vertebrate CD38 sequences, as all venom sequences commence with the N-
terminal sequence, MPFQNS, rather than with proline, as reported by Huang et al. (1988).
Like other vertebrate CD38 sequences, snake venom sequences possess a hydrophilic 14-
residue N-terminus (Fig. 1). In all NADases, immediately C-terminal to this hydrophilic
block, there is a hydrophobic, 25-amino acid segment containing 17 aliphatic residues (L,
V, I, and G), 3 threonine residues, 1 lysine, and 2-3 phenylalanines. These are followed by
another 20 residues that are nearly all hydrophilic. The aliphatic segment almost has the
appearance of a signal peptide (Fig. 1).
Venom NADases are also clearly resolvable into elapid and crotalid sequences. The
Micrurus NADases have 303 amino acids, while crotalid enzymes have 304 and may be
readily distinguished based upon sequence differences at various positions. Coralsnake
and pitviper sequences display the following respective differences: Q/E52, R or Q/W91,
S/R105, H/N145, N/D146, K/N167, D/N170, E/M218, I/T217, N/S219, Q/K224, K/E240,
and probably also G/D253, S/N276, I/S278, T/A301, and T/K303, although the Ovophis
okinavensis and Protobothrops flavoviridis sequences are incomplete at this point (numbered
as in Fig. 1). At several positions, someMicrurus sequences show the crotalid residue while
others have a different amino acid.
The M. surinamensis apoprotein has a monomeric molecular weight of 34,206 Da and
a predicted pI of 7.93, using the Expasy Compute pI/MW tool. The coralsnake enzymes
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Figure 1 Alignment of 10 snake venomNADases with human, frog, and chicken CD38 sequences. The
snake NADase sequences lack signal peptides. They are readily distinguished from the former three se-
quences, and are furthermore clearly resolvable as elapid and crotalid sequences, based upon sequence
differences at various positions. Like the Homo sapiens CD38,Micrurus sequences have 12 cysteines, pre-
sumably arranged in 6 disulfide bonds (Egea et al., 2012). The two complete Protobothrops sequences
have 13 cysteines, like the chicken enzyme, raising the possibility of a covalent homodimer. The truncated
C-terminus of the P. flavoviridis sequence is almost certainly a misassembly or less likely, a pseudogene,
since the last 14 residues (226–239) and the premature stop codon bear no resemblance to the other se-
quences. Asterisks denote stop codons. Accession numbers for other vertebrate sequences: Homo sapiens,
BAA18966.1; Xenopus laevis, BAL72804.1; Gallus gallus, ADQ89191.1; Anolis carolinensis, XP_016848812.
1. Amino acid color scheme: Orange, methionine; Yellow, cysteine; Pink, proline; Gray, aliphatic; Purple,
aromatic; Royal Blue, basic; Red, acidic; Green, hydroxylated; Sky Blue, amidated.
Full-size DOI: 10.7717/peerj.6154/fig-1
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have masses only slightly higher than the 33,500 predicted for the Deinagkistrodon enzyme
(Huang et al., 1988). The Micrurus sequences contain three potential N-glycosylation sites
(NKSL, position 125; NGSI, position 214; NRSI, position 274), based upon results obtained
using the Expasy NetNGlyc 1.0 Server (http://www.cbs.dtu.dk/services/NetNGlyc/). The
first, which is common to elapid and crotalid sequences alike (Fig. 1), has the highest
likelihood of being glycosylated, although it may not be since venom NADases lack signal
peptides. Nonetheless, Huang et al. (1988) reported a carbohydrate content of about 33%
for the Deinagkistrodon NADase, so it seems likely that at least the NKSL at position 125
is N-glycosylated. Based upon analysis with the Expasy NetOGlyc server, there are no
probable O-glycosylation sites (Steentoft et al., 2013).
Higher-level structural attributes of vertebrate NADases
Human CD38 is an ecto-enzyme with a long, helical membrane anchor and an intracellular
N-terminal segment believed to be a random coil (Malavasi et al., 1992; Prasad et al., 1996;
Lee, 2006) (Fig. 2). In addition to its enzymatic activity, CD38 also transduces signals to
the cytoplasm. It is thought to regulate metabolism and participates in the pathogenesis
of diverse maladies such as inflammation, obesity, diabetes, heart disease, asthma, and
aging (Chini et al., 2018). Its enzymatic activity is involved in many of these functions.
Moreover, CD38 has been identified as a cell–surface marker in multiple myeloma and
other blood-related cancers (Chini et al., 2018).
In contrast, snake venom enzymes are soluble rather than membrane-bound (Tatsuki
et al., 1975; Yost & Anderson, 1981), like the Aplysia ADP-ribosyl cyclase (Lee & Aarhus,
1991). While venom NADases could conceivably be membrane-bound in exosomes, they
have not been reported as exosomal enzymes (Ogawa et al., 2008), and their elution on
Sephadex G-100 is appropriate for soluble enzymes of∼100 kDa rather than for exosomes
(Tatsuki et al., 1975). Exosomal embedding seems further unlikely in that all of the venom
NADases reported here possess a very short N-terminal α-helix and a random coil, instead
of the long α-helical membrane anchor of human CD38 (Lee, 2006) (Fig. 2A). Snake venom
NADase residues 45–302 superimpose almost perfectly upon the crystal structure of the
soluble extracellular domain of human CD38, except for the divergent C-termini and the
truncated N-termini (3F6Y_A) (Fig. 2B).
Yost & Anderson (1981) found that the BungarusNADase is a homodimer with a dimeric
mass of 125–130 kDa, and a subunit mass of 62 kDa on reducing SDS-PAGE. Huang et al.
(1988) reported slightly lower values of 98 kDa and 50 kDa for theDeinagkistrodon enzyme,
but apparently employed non-reducing SDS-PAGE, suggesting that the homodimer in that
taxon is non-covalent. Interestingly, our Micrurus sequences have 12 cysteine residues,
arranged in the 3D structure in a manner consistent with 6 disulfide bonds (C68–C84;
C101–C181; C121–C202; C162–C175; C256–C277; C289–C298) (Fig. 2) (Egea et al.,
2012), coinciding exactly with the disulfide bonds in CD38 (Fig. 2C); however, the two
Protobothrops sequences both have a 13th cysteine in the penultimate position (C-terminus),
such that the Protobothrops enzymes could be covalent homodimers (Fig. 1).
The N-terminal 50 residues of the M. surinamensis NADase are slightly hydrophobic,
with aGravy score of 0.142, while theN-terminal 50 residues of humanCD38 (BAA18966.1)
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have a significantly more hydrophobic Gravy score of 0.710. As a result, the soluble venom
enzymes appear to have a slightly more compact N-terminal domain than human CD38
(Fig. 2D).
Many invertebrate and vertebrate enzymes exhibiting NADase activity are
multifunctional, not only hydrolyzing β-NAD(P)+ to nicotinamide and ADP-ribose,
but also exhibiting ADP- and GDP-ribosyl cyclase, and cADPR/cGDPR hydrolase activities
(Howard et al., 1993; Lee, Graeff & Walseth, 1997; Ziegler et al., 1997; Ziegler, Jorcke &
Schweiger, 1997; Augustin, Muller-Steffner & Schuber, 2000; Ferrero et al., 2014). However,
unlike ADP-ribosyl cyclase, human CD38 converts very little β-NAD to cADPR (Lee,
2006).
In contrast tomany invertebrate and vertebrate CD38 homologs,Yost & Anderson (1981)
found that when β-NAD was hydrolyzed by Bungarus fasciatus NADase, nicotinamide and
ADP-ribosewere the sole products. TheB. fasciatus enzymedoes not catalyze the conversion
of β-NAD to cyclic ADP-ribose (cADPR). This lack of cyclase activity results in part from
the presence of a disulfide bond (C124–C206 in Fig. 1; C121–C202, actual) which is
absent in Aplysia ADP-ribosyl cyclase (Tohgo et al., 1994). Moreover, this disulfide bond
is present in all snake venom NADases for which we have sequences. Graeff et al. (2009)
reported that mutation of Phe221 inAplysiaADP-ribosyl cyclase (Phe227 in Fig. 1) reduced
cADPR production and increased ADPR liberation. Consistent with this conclusion, all
snake NADases and at least some vertebrate CD38s have isoleucine in this position (Fig. 1),
effectively preventing cADPR formation. Snake venomNADases also all have the conserved
TLEDTL (144–149) sequence (Fig. 2A) (residues 149–154 in Fig. 1) that forms the bottom
of the active site pocket (Lee, 2006), and the catalytic residue, Glu226 (Glu232 in Fig. 1),
which are present in all CD38 molecules (Graeff et al., 2001). Substitution of Glu-146 with
Phe, Asn, Gly, Asp, Leu, or Ala resulted in cyclase activity up to 9x higher than of wild-type
CD38 (Graeff et al., 2001).
Genome location of vertebrate NAD glycohydrolases/ADP-ribosyl
cyclases
We performed genome-wide BLAST searches to locate the NAD glycohydrolase gene in
the genomes of Homo sapiens, Gallus gallus, Alligator mississippiensis, Anolis carolinensis,
Protobothrops mucrosquamatus, Python bivitattus, Thamnophis sirtalis, and Xenopus laevis.
After locating the genes, we manually checked their sequences and compared them with
existing annotations of transcriptomic and proteomic data.
In the genomes surveyed, NAD glycohydrolase, CD38, is located in the vicinity of the
CC2D2A and PROM1 genes (Ch1L in Xenopus laevis, Ch4 in Homo sapiens and Gallus
gallus), usually directly downstream from the FGFBP1 gene. Non-squamate vertebrates
have a duplicate gene, called BST1, located upstream from CD38. Squamates apparently
lack BST1 in this region, probably due to clade-specific gene loss.
Gene structure of vertebrate NAD glycohydrolases/ADP-ribosyl
cyclases
Human CD38 displays similar intron-exon architecture to that seen in the invertebrate,
Aplysia kurodai ADP-ribosyl cyclase (Nata et al., 1995), suggesting that this architecture
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Figure 2 The predicted 3D structure of a soluble venomNADase is more compact than that of its
membrane-bound human homolog, owing to its somewhat condensed, soluble N-terminus. The en-
zyme fromMicrurus surinamensis venom (left) is compared with human CD38 (right). (A) Venom en-
zymes lack the membrane-spanning alpha-helix and the intracellular domain (residues 1–44) of human
CD38. Venom enzymes possess a soluble random coil instead. The two models are shown as ribbon (con-
tinued on next page. . . )
Full-size DOI: 10.7717/peerj.6154/fig-2
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Figure 2 (. . .continued)
structures with rainbow coloring to distinguish different regions from the N- (blue) to the C-terminus
(red). (B) Superimposed portions of the two structures, corresponding to the soluble domain of human
CD38, modeled upon the crystal structure of the soluble domain of human CD38 (3F6Y_A). The two
structures superimpose almost perfectly except for the divergent C-termini and the truncated N-termini.
Residues 45–300 of theM. surinamensis NADase (red) and residues 45–296 of human CD38 (blue) are
shown. Left, frontal view; Right, left-side view. (C) Disulfide bonds are identical in theM. surinamensis
NADase and human CD38. The Cys121–Cys202 disulfide bond, in combination with other residues, helps
to prevent ADP-ribosyl cyclase activity, forcing the conversion of β-NAD and other suitable substrates to
ADP-ribose, which is subsequently hydrolyzed to adenosine, the strategic target. (D) TheM. surinamensis
NADase and human CD38 are both hydrophilic overall, with Gravy scores of−0.292 and−0.306, respec-
tively. However, while the N-terminal 44 residues of theM. surinamensis NADase are slightly hydropho-
bic (0.142), the N-terminus of CD38 is strongly hydrophobic (0.710). Gravy scores below 0 are more likely
globular, hydrophilic proteins, while scores above 0 are more likely membrane-bound and hydrophobic
(Magdeldin et al., 2012). Surfaces are rendered to show Kyte-Doolittle hydrophobicity with blue residues
being most hydrophilic and red residues being most hydrophobic. Models were created with GalaxyTBM
using human CD38 (3F6Y) as a template (Ko et al., 2012) . Disulfide bond formation, energy minimiza-
tion, and structural manipulations were performed using Chimera 1.13 (Pettersen et al., 2004).
Figure 3 Structure of the NAD glycohydrolase gene from the genome of Protobothrops mucrosquamatus (Aird et al., 2017a), showing locations
of the 8 exons, and the amino acid sequence of the enzyme expressed in the venom glands. The mature venom protein comprises 304 amino acids
linked by six disulfide bonds. Exon 1 actually encodes part of the 5′-untranslated region, as well as the N-terminus of the protein, and Exon 8 ex-
tends well beyond the stop codon, but only the mature protein sequence is shown here. Because of split arginine codons that bridge the Exon 6–7
and 7–8 boundaries, splicing out the sixth exon in the short P. mucrosquamatus NADase variants would retain the arginine after the splice. Distances
between exons shown above are for purposes of illustration only, and are not proportionally scaled.
Full-size DOI: 10.7717/peerj.6154/fig-3
is highly conserved. It comprises eight exons, extending more than 77 kb in the human
genome (Nata et al., 1997). However, in Protobothrops mucrosquamatus (and presumably
in other venomous snakes) the 8-exon gene is transcribed in two variants, a long NADase
similar to CD38 of other vertebrates (Fig. 3), and a shorter form that lacks exon 6 (Fig. 4).
Exon 6 contains no cysteines, and its deletion results in the loss of 31 amino acids from
Ser223-Gln253 (Fig. 4A). Owing to the presence of split arginine codons at both the
exon 6–7 and exon 7–8 boundaries, no amino acid substitution occurs in the shortened
(272-residue) structure. Instead, the effect of removing these 31 residues is to delete the
loose helical region (Ser223-Gln253) from the center of themolecule, including the essential
catalytic residue, Glu229 (Fig. 4A; Glu232 in Fig. 1), while leaving the remainder of the
structure essentially intact (Fig. 4B). If this protein is expressed, it is difficult to imagine
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Figure 4 In Protobothrops mucrosquamatus, the 8-exon gene is transcribed into a long NADase and a
shorter form that lacks exon 6. (A) Its deletion results in the loss of 31 amino acids from Ser223-Gln253.
With split arginine codons at both the exon 6–7 and exon 7–8 boundaries, no amino acid substitution
occurs in the shortened (272-residue) structure. (B) The effect of removing these 31 residues is to delete
the loose helical region (Ser223-Gln253) from the center of the molecule, including the catalytic residue,
Glu229, (Glu232 in Fig. 1) leaving the remainder of the structure essentially intact. If this alternately
spliced protein is expressed, it is difficult to imagine what its function might be. Models were created
using GalaxyTBM (Ko et al., 2012). Disulfide bond formation, energy minimization, and structural
manipulations were performed using Chimera 1.13 (Pettersen et al., 2004). Amino acid classes are colored
as in Fig. 1.
Full-size DOI: 10.7717/peerj.6154/fig-4
what its function might be, but with its precise alternate splicing, this does not seem like a
pseudogene.
CONCLUSIONS
All snake venom gland transcriptomes and venomous snake genomes published to date
contain sequences for NAD glycohydrolases, pointing to a significant role in envenomation.
At least some crotalids may produce two forms of this enzyme. Strategically, the function
of snake venom NADases is to drive the release of adenosine from NADP and β-NAD in
prey tissues and to block its conversion to cADPR. Guanosine is also released from NGD.
Both purines contribute to prey immobilization via hypotension/circulatory shock and
paralysis caused by neurosuppression (Aird, 2002; Aird, 2009).
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